Biologics in the management of pediatric inflammatory bowel disease: When and what to choose

doi:10.5409/wjcp.v14.i1.100938

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (912)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-6) series.

Item

Count

PDF

HTML

374

Figures (1-4)

Tables (1-6)

Sum=557

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

149

Sum=225

Publishing Process of This Article

Item

Count

Browse

Download

Sum=71

Mar 9, 2025 (publication date) through Feb 9, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Pediatrics

ISSN

2219-2808

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Clin Pediatr. Mar 9, 2025; 14(1): 100938
Published online Mar 9, 2025. doi: 10.5409/wjcp.v14.i1.100938

Full Size Figure Download Figure

Figure 4 Biologics in children with inflammatory bowel disease: Choice of therapy and future perspectives. IBD: Inflammatory bowel disease; TNFα:Tumor necrosis factor alpha; Anti-α4β7: Anti-alpha4beta7; IL: Interleukin; JAK: Janus kinase; IFX: Infliximab; HLA: Human leukocyte antigen; DTT: Dual-targeted therapy; IM: Immunomodulators; AZA: azathioprine; MTX: Methotrexate; TDM: Therapeutic drug monitoring; PIBD: Pediatric inflammatory bowel disease.

Citation: Samanta A, Srivastava A. Biologics in the management of pediatric inflammatory bowel disease: When and what to choose. World J Clin Pediatr 2025; 14(1): 100938
URL: https://www.wjgnet.com/2219-2808/full/v14/i1/100938.htm
DOI: https://dx.doi.org/10.5409/wjcp.v14.i1.100938